| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/26/2014 | CN102065888B Anti-VEGF antibody |
| 03/26/2014 | CN101821292B Combination therapy with type I and type II anti-cd20 antibodies |
| 03/26/2014 | CN101708333B Multivalent vaccine composition |
| 03/26/2014 | CN101516395B A vaccine for chikungunya virus infection |
| 03/25/2014 | US8680247 Monoclonal antibodies against glypican-3 |
| 03/25/2014 | US8680241 Humanized antibodies specific for HSP65-derived peptide-6 methods and uses thereof |
| 03/25/2014 | US8680239 Use of RGM and its modulators |
| 03/25/2014 | US8680236 Altered OspA of borrelia burgdorferi |
| 03/25/2014 | US8680233 Heteropeptides useful for reducing nonspecific adsorption |
| 03/25/2014 | US8680152 Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain |
| 03/25/2014 | US8680092 Nitrogenous heterocyclic compound and medicinal use thereof |
| 03/25/2014 | US8680068 Herpes virus strains |
| 03/25/2014 | US8680046 Inhibitors of viral integrase and methods of use |
| 03/25/2014 | US8679835 Tumor-initiating cells and methods of use |
| 03/25/2014 | US8679830 Viral vectors |
| 03/25/2014 | US8679819 Mutant cells with altered sialic acid |
| 03/25/2014 | US8679785 Knobs and holes heteromeric polypeptides |
| 03/25/2014 | US8679762 Method of detecting hepatitis B virus s antigen |
| 03/25/2014 | US8679540 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications |
| 03/25/2014 | US8679510 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| 03/25/2014 | US8679509 Oncolytic viruses and methods for treating neoplastic disorders |
| 03/25/2014 | US8679506 Glucan-based vaccines |
| 03/25/2014 | US8679505 Compositions for immunising against Staphylococcus aureus |
| 03/25/2014 | US8679504 Poultry viral materials and methods related thereto |
| 03/25/2014 | US8679503 Methods, compositions and kits relating to chitnases and chitnase-like molecules and inflammation disease |
| 03/25/2014 | US8679502 Monoclonal antibodies that bind to HGM-CSF and medical compositions comprising same |
| 03/25/2014 | US8679501 Method for modulating inflammatory responses |
| 03/25/2014 | US8679500 Compositions containing antibodies for treating CD5+ HLA-DR+ B or T cell related diseases |
| 03/25/2014 | US8679499 Methods for relieving asthma-associated airway hyperresponsiveness |
| 03/25/2014 | US8679498 Anti-N3PGLU amyloid beta peptide antibodies and uses thereof |
| 03/25/2014 | US8679497 Anti-ferroportin 1 monoclonal antibodies and uses thereof |
| 03/25/2014 | US8679496 Anti-serum albumin single variable domains |
| 03/25/2014 | US8679495 Use of anti-90K monoclonal antibodies for the prevention and treatment of tumors and metastases thereof |
| 03/25/2014 | US8679494 Antibodies specific to IL-17A and IL-17F |
| 03/25/2014 | US8679493 Immunoglobulin Fc polypeptides |
| 03/25/2014 | US8679492 Humanized antibodies that bind to CD19 and their uses |
| 03/25/2014 | US8679491 Method of modulating the activity of functional immune molecules |
| 03/25/2014 | US8679490 Binding polypeptides with diversified and consensus VH/VL hypervariable sequences |
| 03/25/2014 | US8679489 Inhibiting cell migration |
| 03/25/2014 | US8679488 Targeting of bone marrow neovasculature |
| 03/25/2014 | US8679487 Anti-interleukin-4 receptor antibodies |
| 03/25/2014 | US8679485 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 03/25/2014 | US8679484 Method for removal of toxins from mucosal membranes |
| 03/25/2014 | US8679476 Interferon-β production modulating Listeria strains and methods for using same |
| 03/25/2014 | US8678184 Methods for producing vaccine adjuvants |
| 03/25/2014 | CA2753899C Polyalkylene glycol with moiety for conjugating biologically active compounds |
| 03/25/2014 | CA2676529C Genetically recombinant antibody composition having enhanced effector activity |
| 03/25/2014 | CA2673592C Methods for the treatment of il-1.beta. related diseases |
| 03/25/2014 | CA2565247C Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 03/25/2014 | CA2537896C East coast fever vaccine based on ctl-specific schizont antigens |
| 03/25/2014 | CA2507018C Materials and methods for preventing and treating microbe-mediated epithelial disorders |
| 03/25/2014 | CA2474011C Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders |
| 03/25/2014 | CA2445826C Treatment and diagnosis of macrophage mediated disease |
| 03/25/2014 | CA2435000C Oligomeric complexes of chimeric proteins with enhanced immunogenic potential |
| 03/25/2014 | CA2404448C Genes involved in intestinal inflammatory diseases and use thereof |
| 03/25/2014 | CA2368369C Docetaxel in combination with rhumab her2 for the treatment of cancers |
| 03/20/2014 | WO2014043593A2 Programmable drug delivery profiles of tumor-targeted bacteria |
| 03/20/2014 | WO2014043523A1 Compositions and methods for rendering tumor cells susceptible to cd8+ t cell-mediated killing |
| 03/20/2014 | WO2014043518A1 Brachyury protein, non-poxvirus non-yeast vectors encoding brachyury protein, and their use |
| 03/20/2014 | WO2014043509A2 Antigen binding molecule with terminal modifications |
| 03/20/2014 | WO2014043484A2 Metabolic remodeling of the tumor microenvironment: migration stimulating factor (msf) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth |
| 03/20/2014 | WO2014043480A1 Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies |
| 03/20/2014 | WO2014043403A1 Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymerase |
| 03/20/2014 | WO2014043386A1 Clonal lineage antibodies |
| 03/20/2014 | WO2014043331A2 Specific phospho-forms of elk-1 as biomarkers and therapeutic targets for cancer |
| 03/20/2014 | WO2014043223A1 Irhom2 inhibition for the treatment of complement mediated disorders |
| 03/20/2014 | WO2014043215A1 Bi-specifc diabodies for masking and targeting vaccines |
| 03/20/2014 | WO2014043189A1 Conditionally replication deficient herpes viruses and use thereof in vaccines |
| 03/20/2014 | WO2014042780A1 Compositions and methods for treating an active mycobacterium tuberculosis infection |
| 03/20/2014 | WO2014042669A1 Antibody evolution immunogens |
| 03/20/2014 | WO2014042493A1 Novel epitope of ip-10 and antibody to same |
| 03/20/2014 | WO2014042305A1 Icam－1 antibody and use thereof |
| 03/20/2014 | WO2014042185A1 Screening method for medicines for treating inflammatory disease |
| 03/20/2014 | WO2014042167A1 Monoclonal antibody against ebag9, hybridoma, and application for monoclonal antibody against ebag9 |
| 03/20/2014 | WO2014042148A1 Cancer marker and application thereof |
| 03/20/2014 | WO2014041784A1 Ube2t peptides and vaccines containing the same |
| 03/20/2014 | WO2014041427A1 A pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent |
| 03/20/2014 | WO2014041307A1 Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, method for the production thereof and use of same |
| 03/20/2014 | WO2014041189A1 Salmonid alphavirus and uses thereof |
| 03/20/2014 | WO2014041078A1 Recombinant fc-fusion protein of the two immunoglobulin domains of unc5 |
| 03/20/2014 | WO2014041069A1 Human islet amyloid polypeptide (hiapp) specific antibodies and uses thereof |
| 03/20/2014 | WO2014041035A1 Diagnostic method for detecting an autoimmune disease and related subject-matter |
| 03/20/2014 | WO2014040251A1 Isocitrate dehydrogenase 1 as diagnostic and prognostic biomarker and therapeutic target for lung cancer |
| 03/20/2014 | WO2014022679A3 Anti-etbr antibodies and immunoconjugates |
| 03/20/2014 | WO2014021693A3 Novel monoclonal antibody which is specifically bound to tm4sf5 protein and use thereof |
| 03/20/2014 | WO2014016702A3 Humanized forms of monoclonal antibodies to human gnrh receptor |
| 03/20/2014 | WO2013181471A3 Matrix metalloproteinase cleavable protein polymers for cancer gene therapy |
| 03/20/2014 | WO2013028153A3 Method and apparatus for removing noxious materials from cells |
| 03/20/2014 | WO2013019906A9 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors |
| 03/20/2014 | WO2012112696A8 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells |
| 03/20/2014 | WO2010151840A3 Albumin-free botulinum toxin formulations |
| 03/20/2014 | US20140080997 Novel mite allergen |
| 03/20/2014 | US20140079793 Combinations and modes of administration of therapeutic agents and combination therapy |
| 03/20/2014 | US20140079771 Methods and compositions for treatment of metabolic disorders |
| 03/20/2014 | US20140079738 Self-gelatinizable nucleic acid |
| 03/20/2014 | US20140079736 Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria |
| 03/20/2014 | US20140079735 Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof |
| 03/20/2014 | US20140079733 Compositions for Canine Respiratory Disease Complex |
| 03/20/2014 | US20140079732 Combination vaccines |
| 03/20/2014 | US20140079730 Composition comprising vlp and amyloid beta peptide |